Leonteq Securities’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
Other funds holding CORT
Leonteq Securities's CORT Position: Q3 2026 in Review
Leonteq Securities reduced its Corcept Therapeutics (CORT) stake by 6.7% in Q3 2026, selling an estimated $2.69K and leaving 350 shares worth $40.3K. The position accounts for ﹤0.01% of the portfolio, ranked #819.
Leonteq Securities first reported a position in CORT in Q2 2021 and has held it in 5 quarters since. 409 funds tracked by Wall St. Rank hold CORT as of Q3 2026.
- Leonteq Securities held 350 shares of Corcept Therapeutics worth $40.3K as of Q3 2026.
- Leonteq Securities sold 25 Corcept Therapeutics shares in Q3 2026, an estimated $2.69K.
- Corcept Therapeutics made up ﹤0.01% of Leonteq Securities's portfolio in Q3 2026, its #819 holding.
- Leonteq Securities first reported a position in Corcept Therapeutics in Q2 2021 and has held it in 5 quarters since.
- 409 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2026.
Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.